Obesity & Metabolic Health

GLP-1 Medications and the End of the Diet Industry as We Know It

George Padron
Specialty Medicine, Healthcare Headlines, Obesity & Metabolic Health | Apr 6, 2026
A Medscape commentary contends that GLP-1 medications producing 20%+ weight loss are ending the era of diet-based weight management and reshaping the field.

Walgreens Enters GLP-1 Telehealth, Focusing on Self-Pay Gap

Sonia Reyes
AI & Critical Decision Support, Digital Therapeutics, Healthcare Headlines, Telehealth & Virtual Care, Obesity & Metabolic Health | Mar 21, 2026
Walgreens Weight Management offers virtual GLP-1 visits for $49 with no monthly fee, targeting the 80% of large employers that don't cover weight-loss drugs.

White-Label Medical Groups Draw Regulatory Scrutiny in GLP-1 Telehealth Crackdown

George Padron
Healthcare Headlines, Policy & Legislation, Telehealth & Virtual Care, Obesity & Metabolic Health | Mar 18, 2026
A STAT News investigation finds that four medical groups are linked to 30% of FDA-warned GLP-1 telehealth companies, raising legal and patient safety concerns for payers.

Novo Nordisk and Hims & Hers End Patent Dispute

George Padron
Healthcare Headlines, Obesity & Metabolic Health | Mar 16, 2026
Novo Nordisk and Hims & Hers settled a patent dispute March 9, with Hims agreeing to sell FDA-approved Wegovy and Ozempic and stop advertising compounded semaglutide products.

Nutrition Gains Importance in Medical School Curriculum Overhaul

George Padron
Obesity & Metabolic Health | Mar 9, 2026
Over 50 U.S. medical schools have committed to expanding nutrition education, aiming for 40 hours of instruction by fall 2026 amid concerns about chronic disease.